Industry
Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
Total Companies
1 352
1 301 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$1 144.5 |
-0.9%
|
$1.1T |
|
|
|
Johnson & Johnson
JNJ
|
$258.23 |
+0.9%
|
$621.6B |
|
|
|
Roche Holding AG
ROG
|
CHf324.9 |
+4.1%
|
$325.6B |
|
|
|
Merck & Co Inc
MRK
|
$130.6 |
+0.6%
|
$322.6B |
|
|
|
Novartis AG
NOVN
|
CHf126.38 |
-0.3%
|
$298.7B |
|
|
|
AstraZeneca PLC
AZN
|
12 632 |
-0.7%
|
$264.1B |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr306.85 |
-7.3%
|
$209.5B |
|
|
|
Nuvo Pharmaceuticals Inc
MRV
|
CA$29.81 |
+12.2%
|
$155.5B |
|
|
|
Pfizer Inc
PFE
|
$25.145 |
+0.9%
|
$143.3B |
1 296 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account
